...Biovian’s position as a trusted, quality player in the CDMO market with a clear focus on Viral vectors and recombinant proteins. Download Press Release Biovian announces a new CEO Download...
...adeno-associated virus (AAV) vector–based therapies? What kinds of concerns do small and mid-sized gene therapy companies (SMEs) have when they come to you? What can a CDMO like Biovian offer...
...service agreement that covers production, purification, filling and labeling is a good example of our One-Stop-Shop concept, where multiple services are provided under the same roof. Download Press Release Download...
...“In searching for a CDMO that could deliver on these goals, Lokon found a perfect partner in Finnish CDMO Biovian.” Download article Manufacturing the next generation of cancer immunotherapeutics Download...
...bigger clients when reserving CDMO resources. We understand that early-stage trials require fast response, a high degree of customization, and flexibility in production.” Download Magazine European Biotechnology Spring 2021 Download...
...article, or download a copy. Download Smooth Collaboration Between CDMOs and Tech Providers Boosts AAV Manufacturing Efficiency When you’re starting a new gene therapy company, you must decide what to...
The article compares the manufacture of viral vectors with that of recombinant proteins and reveals how Biovian has developed a solution to address the continuing challenges in gene therapy production....
...JCI Turku, Finland on Friday, 10th November 2023. JCI Turku, Finland has awarded local people, companies, organizations, communities, and acts with the Turku Developer award since 1988. The award is given upon...
...filling line. The project is an example of how knowledge and collaboration can make a complex project successful. Ulla Myllymaa from Biovian comments: “It was important for us to invest...
...Biovian means that we can conduct our activities with continuity, since they also have their own GMP facility for the manufacture of products for clinical studies. -CEO Hans Arwidsson https://news.cision.com/eurocine-vaccines/r/eurocine-vaccines-has-selected-biovian-as-contract-developer-for-the-chlamydia-vaccine-candidate,c3263137...
